These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1586776)

  • 1. Immunological abnormalities in haemophiliacs.
    Watson HG; Ludlam CA
    Blood Rev; 1992 Mar; 6(1):26-33. PubMed ID: 1586776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates.
    Kaplan J; Sarnaik I; Lusher J
    Clin Immunol Immunopathol; 1988 Mar; 46(3):337-41. PubMed ID: 3257429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilia, blood products and HIV infection.
    Lowe GD
    Scott Med J; 1987 Aug; 32(4):109-11. PubMed ID: 3672104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated.
    Fabio G; Smeraldi RS; Gringeri A; Marchini M; Bonara P; Mannucci PM
    Br J Haematol; 1990 Aug; 75(4):531-6. PubMed ID: 2207004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HIV infection and immunity disorders in patients with hemophilia].
    Gotić M; Rolović Z; Brkić S; Vucković S; Bujko M; Lilić D; Dujić A
    Srp Arh Celok Lek; 1989; 117(11-12):737-50. PubMed ID: 2490991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell dysfunction in haemophilia in the absence and presence of HIV-1 infection.
    Madhok R; Gracie JA; Forbes CD; Lowe GD
    Thromb Haemost; 1991 Jan; 65(1):7-10. PubMed ID: 2024240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Median time from seroconversion to AIDS in Italian HIV-positive haemophiliacs: different parametric estimates.
    Chiarotti F; Palombi M; Schinaia N; Ghirardini A; Bellocco R
    Stat Med; 1994 Jan; 13(2):163-75. PubMed ID: 8122052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective antibodies to hepatitis B virus in haemophiliacs.
    Oon LL; King A; Higgins JA; Lee CA; Kernoff PB; Goodall AH
    J Med Virol; 1991 Jan; 33(1):19-25. PubMed ID: 1826737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to multiple skin test antigens in haemophiliacs.
    McIvor RA; McCluskey DR; Mayne EE; McKirgan J
    Ulster Med J; 1987 Oct; 56(2):95-9. PubMed ID: 3445399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in HIV-negative and HIV-positive haemophiliacs.
    Naimi N; Plancherel C; Bosser C; Jeannet M; de Moerloose P
    Blood Coagul Fibrinolysis; 1990; 1(1):5-8. PubMed ID: 2102789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR analysis of HIV-1 sequences and differential immunological features in seronegative and seropositive haemophiliacs.
    Chelucci C; Hassan HJ; Gringeri A; Macioce G; Mariani G; Santagostino E; Testa U; Vulcano F; Mannucci PM; Peschle C
    Br J Haematol; 1992 Aug; 81(4):558-67. PubMed ID: 1390244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
    Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E
    Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological effects of intermediate purity clotting factor concentrates: failure to affect lymphocyte activation in vivo.
    Higgins JA; Giangrande PL; Kernoff PB; Goodall AH
    Br J Haematol; 1993 Feb; 83(2):296-305. PubMed ID: 8457478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of immunoglobulin classes and IgG subclasses of platelet-associated immunoglobulin in HIV-seropositive haemophiliacs.
    Taaning E; Scheibel E; Laursen B; Ingerslev J
    Vox Sang; 1988; 54(4):205-9. PubMed ID: 3388817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia growth and development study. Design, methods, and entry data.
    Hilgartner MW; Donfield SM; Willoughby A; Contant CF; Evatt BL; Gomperts ED; Hoots WK; Jason J; Loveland KA; McKinlay SM
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):208-18. PubMed ID: 8498644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and humoral immune responses in haemophiliacs after vaccination against tick-borne encephalitis.
    Wolf HM; Pum M; Jáger R; István L; Mannhalter JW; Eibl MM
    Br J Haematol; 1992 Oct; 82(2):374-83. PubMed ID: 1419820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia.
    Cohen H; Mackie IJ; Anagnostopoulos N; Savage GF; Machin SJ
    J Clin Pathol; 1989 Jun; 42(6):629-33. PubMed ID: 2500459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project.
    Fricke W; Augustyniak L; Lawrence D; Brownstein A; Kramer A; Evatt B
    Transfusion; 1992 Oct; 32(8):707-9. PubMed ID: 1412676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of hepatitis A virus in Japanese haemophiliacs.
    Hayashi K; Fukuda Y; Nakano I; Katano Y; Nagano K; Yokozaki S; Hayakawa T; Toyoda H; Takamatsu J
    J Infect; 2001 Jan; 42(1):57-60. PubMed ID: 11243755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of HIV infection in Swedish haemophiliacs.
    Berntorp E; Jarevi G; Wedbäck A; Böttiger B; Hansson BG; Nordenfelt E; Nilsson IM
    Eur J Haematol; 1989 Mar; 42(3):254-8. PubMed ID: 2494056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.